The Ubika Marijuana 20 Index has trended upwards since our last report dated September 11, 2017, returning 19%, as it outperformed both its benchmarks, the TSX-V Index and the Horizons Marijuana Life Sciences Index over the same period, which returned 1%, and 13%, respectively. We highlight that 17 of the 20 constituents posted gains over the last couple of months following significant developments on the regulatory front, which culminated in Ontario’s announcement regarding its plans for legalization.
Notable Performers in this report include:
CannTrust Holdings Inc. (CSE:TRST), which gained 104% following its IPO on August 21.
OrganiGram Holdings Inc. (TSXV:OGI), which increased 31% after the announcement of a supply agreement with New Brunswick for recreational marijuana.
Aphria Inc. (TSX:APH), whose stock fell 11% on October 17, as the Company announced an equity financing for $80M at $7.25 per share.
Disclosure: Neither the author nor any of the principals at SmallCapPower, or their family members, own units in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
